Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ASTELLAS PHARMA EUROPE B V”

2 pharma patents match "ASTELLAS PHARMA EUROPE B V" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 2 pharmaceutical patents matching "ASTELLAS PHARMA EUROPE B V" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2 results for “ASTELLAS PHARMA EUROPE B V” · 30,257 patents in full index Clear search

  1. CN 120418289

    Combination therapy of bispecific binding agents that bind to CLDN18.2 and CD3 with immune checkpoint inhibitors

    ASTELLAS PHARMA EUROPE B V · Granted Aug 1, 2025 · Expires Jul 27, 2045

    granted
  2. KR 20240032847

    CLDN18.2 및 CD3에 결합하는 이중특이 결합제

    ASTELLAS PHARMA EUROPE B V [NL] · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted